Home › Funds › American Century › Avantis Inflation Focused Equity ETF
Fund family: American Century · Filed by AMERICAN CENTURY ETF TRUST (CIK 1710607) · SEC series S000077485
Ticker: AVIE (C000237946)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 3,514 with, 64 against, 0 abstentions (not counted as with management); 4 items carried no recommendation. Shareholder proposals: 9 FOR, 55 AGAINST, 0 abstained, by the filing’s own vote-source field.
The same two figures as American Century’s manager page (564,755 ballot items across 76 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | American Century | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 89.9% | 3,421 | 88.0% | 451,178 |
| Backed environmental and social shareholder proposals at US companies | n/a | 22 | 2.0% | 2,319 |
Each ballot item this fund voted is set against the votes of the other American Century funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted differently from most American Century funds on 2 items (0.1% of the 3,295 items where a comparison was possible).
| Company | Meeting | Item | This fund | Most American Century funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| Akero Therapeutics, Inc. | 2025-12-02 | To approve, on an advisory, non-binding basis, the payment of certain compensation that may be paid or become payable by Akero to its named executive officers in connection with the Merger. | Against | FOR — 5 of 6 American Century funds | Against | Approved, 98.0% support |
| Philip Morris International Inc. | 2026-05-06 | Election of Directors: Kalpana Morparia | For | AGAINST — 3 of 4 American Century funds | For | Elected, 94.0% support |
Download all 2 differences (CSV)
The same votes as “with management” above, by the sector of the company voted on. 96.1% of this fund’s 3,578 such votes could be given a sector; the other 141 (3.9%) are at companies without one and are not in the table.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Energy | 779 | 7 | 0.9% |
| Health Care | 731 | 21 | 2.9% |
| Finance | 664 | 12 | 1.8% |
| Industrials | 440 | 4 | 0.9% |
| Consumer Discretionary | 276 | 10 | 3.6% |
| Consumer Staples | 227 | 9 | 4.0% |
| Basic Materials | 140 | 0 | 0.0% |
| Utilities | 119 | 1 | 0.8% |
| Real Estate | 30 | 0 | 0.0% |
| Miscellaneous | 21 | 0 | 0.0% |
| Technology | 10 | 0 | 0.0% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 2,530 | 4 |
| Say-on-Pay | 353 | 0 |
| Audit-related | 349 | 0 |
| Compensation | 143 | 2 |
| Corporate Governance | 122 | 35 |
| Capital Structure | 44 | 0 |
| Extraordinary Transactions | 31 | 1 |
| Environment or Climate | 11 | 11 |
| Shareholder Rights and Defenses | 9 | 0 |
| Other Social Issues | 6 | 6 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| Berkshire Hathaway Inc. | May 2, 2026 | $647,742 | 16 | 1 |
| Exxon Mobil Corporation | May 27, 2026 | $578,085 | 17 | 2 |
| Eli Lilly and Company | May 4, 2026 | $478,806 | 10 | 2 |
| Chevron Corporation | May 27, 2026 | $312,739 | 17 | 3 |
| AbbVie Inc. | May 8, 2026 | $269,301 | 8 | 1 |
| The Procter & Gamble Company | October 14, 2025 | $254,516 | 18 | 1 |
| Johnson & Johnson | April 23, 2026 | $239,565 | 15 | 1 |
| The Coca-Cola Company | April 29, 2026 | $226,690 | 19 | 5 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| May 2, 2026 | Berkshire Hathaway Inc. | Shareholder proposal requesting that the Company issue a report disclosing the Board's oversight framework for workforce and human-capital management across its operating subsidiaries. Shareholder proposal | Against | For |
| May 27, 2026 | Exxon Mobil Corporation | Independent Chair, a proposal overwhelmingly defeated on 16 separate occasions since 2000 Shareholder proposal | Against | For |
| May 27, 2026 | Exxon Mobil Corporation | Proposal requesting Company to modify its Voluntary Retail Voting Program to provide multiple options not aligned with the Board's recommendations Shareholder proposal | Against | For |
| May 4, 2026 | Eli Lilly and Company | Shareholder proposal to adopt a policy and amend the bylaws to require an independent board chair. Shareholder proposal | Against | For |
| May 4, 2026 | Eli Lilly and Company | Shareholder proposal to prepare an annual lobbying report. Shareholder proposal | Against | For |
| May 27, 2026 | Chevron Corporation | Adopt an Independent Chair Shareholder proposal | Against | For |
| May 27, 2026 | Chevron Corporation | Report on Indigenous Peoples' Rights Shareholder proposal | Against | For |
| May 8, 2026 | AbbVie Inc. | Stockholder Proposal - to Adopt a Policy to Require an Independent Chair Shareholder proposal | Against | For |
| October 14, 2025 | The Procter & Gamble Company | Shareholder Proposal Requesting Additional Reporting on Plastic Packaging Shareholder proposal | Against | For |
| April 23, 2026 | Johnson & Johnson | Independent Board Chair Shareholder proposal | Against | For |
| April 29, 2026 | The Coca-Cola Company | Vote on a shareowner proposal requesting a sustainability committee by-law amendment Shareholder proposal | Against | For |
| April 29, 2026 | The Coca-Cola Company | Vote on a shareowner proposal requesting a report evaluating the Company's plastics packaging policies Shareholder proposal | Against | For |
Meetings with a proxy contest or competing nominees (2 in 2025-2026), and how the fund voted the items on its ballot.
3,604 ballot items at 368 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, Avantis Inflation Focused Equity ETF (AVIE) voted at 368 shareholder meetings of 353 companies, on 3,604 ballot items in all. Where management made a recommendation, the fund followed it on 98.2% of the items and voted against it 64 times. Its most frequent area of disagreement was corporate governance (35 of its votes against management). It voted FOR 14.1% of the 64 shareholder proposals on which it cast a FOR or AGAINST vote. It voted FOR the board's own proposals more often than American Century's funds as a whole (89.9% against 88.0%). It voted differently from most American Century funds on 2 items. 2 of its meetings were contested.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of American Century’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.